Literature DB >> 20633638

Jailbreak: oncogene-induced senescence and its evasion.

Fiona K E McDuff1, Suzanne D Turner.   

Abstract

Aberrant oncogenic signals are typically counteracted by anti-proliferative mechanisms governed principally by the p53 and Rb tumour-suppressor proteins. Apoptosis is firmly established as a potent anti-proliferative mechanism to prevent tumour growth but it is only in recent years that oncogene-induced senescence has achieved similar recognition. Senescence is defined as an irreversible cell-cycle arrest suggesting that entry of oncogene-expressing cells into this static yet viable state is permanent. However, tumours do develop and express the very same oncogenes that landed them in jail. We ask whether this is because rogue incipient cancer cells find ways to escape this imposed imprisonment or otherwise entirely avoid capture by senescence gate-keepers.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20633638     DOI: 10.1016/j.cellsig.2010.07.004

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  19 in total

1.  Alterations in nuclear pore architecture allow cancer cell entry into or exit from drug-resistant dormancy.

Authors:  Yayoi Kinoshita; Tamara Kalir; Jamal Rahaman; Peter Dottino; D Stave Kohtz
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

Review 2.  Oncogene-induced senescence and its role in tumor suppression.

Authors:  Jay P Reddy; Yi Li
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-06-18       Impact factor: 2.673

Review 3.  Senescence regulation by the p53 protein family.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Methods Mol Biol       Date:  2013

4.  Raf/MEK/ERK can regulate cellular levels of LC3B and SQSTM1/p62 at expression levels.

Authors:  Jin-Hwan Kim; Seung-Keun Hong; Pui-Kei Wu; Alexsia L Richards; William T Jackson; Jong-In Park
Journal:  Exp Cell Res       Date:  2014-08-14       Impact factor: 3.905

Review 5.  The blood-testis barrier and its implications for male contraception.

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Pharmacol Rev       Date:  2011-10-28       Impact factor: 25.468

6.  A mortalin/HSPA9-mediated switch in tumor-suppressive signaling of Raf/MEK/extracellular signal-regulated kinase.

Authors:  Pui-Kei Wu; Seung-Keun Hong; Sudhakar Veeranki; Mansi Karkhanis; Dmytro Starenki; Jose A Plaza; Jong-In Park
Journal:  Mol Cell Biol       Date:  2013-08-19       Impact factor: 4.272

7.  Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells.

Authors:  Michael Y Sherman; Le Meng; Martha Stampfer; Vladimir L Gabai; Julia A Yaglom
Journal:  Aging Cell       Date:  2011-09-16       Impact factor: 9.304

8.  UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma.

Authors:  Raksha Mudbhary; Yujin Hoshida; Yelena Chernyavskaya; Vinitha Jacob; Augusto Villanueva; M Isabel Fiel; Xintong Chen; Kensuke Kojima; Swan Thung; Roderick T Bronson; Anja Lachenmayer; Kate Revill; Clara Alsinet; Ravi Sachidanandam; Anal Desai; Sucharita SenBanerjee; Chinweike Ukomadu; Josep M Llovet; Kirsten C Sadler
Journal:  Cancer Cell       Date:  2014-01-30       Impact factor: 31.743

9.  Growth arrest signaling of the Raf/MEK/ERK pathway in cancer.

Authors:  Jong-In Park
Journal:  Front Biol (Beijing)       Date:  2014-02

Review 10.  Pathological and molecular advances in pediatric low-grade astrocytoma.

Authors:  Fausto J Rodriguez; Kah Suan Lim; Daniel Bowers; Charles G Eberhart
Journal:  Annu Rev Pathol       Date:  2012-10-29       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.